Companies: 10,795·Total market cap: $144.5T
GlobeImmune, Inc.

GlobeImmune, Inc.

GBIMOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$575
P/E Ratio
52W High$0.0005
52W Low$0.000001
Overview

GlobeImmune, Inc. (GBIM) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · GBIM · as of Mar 16, 2016

Latest filing snapshot

2
-20-90.91%vs prior year

GlobeImmune, Inc. (GBIM) employee data is sourced from the annual SEC 10-K filing. As of 2015, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2015-12-31·Full-time · Global
Total Employees
2
Change (1Y)
-20
Growth % (1Y)
-90.91%
Revenue / Employee
$3.23M
Net Income / Employee
$-1.38M
Market Cap
$0M

GBIM Employee Count

2014 – 2015 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2016-03-162-20-90.91%
2015-03-1722

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Anthera Pharmaceuticals, Inc.
ANTH
Anthera Pharmaceuticals, Inc.
21
#2
Comera Life Sciences Holdings, Inc.
CMRA
Comera Life Sciences Holdings, Inc.
12
#3
Imagenetix, Inc.
IAGX
Imagenetix, Inc.
5
#4
FluoroPharma Medical, Inc.
FPMI
FluoroPharma Medical, Inc.
4
#5
Neurobiological Technologies, Inc.
NTII
Neurobiological Technologies, Inc.
4
#6
GlobeImmune, Inc.
GBIM
GlobeImmune, Inc.YOU
2
#7
OncoVista Innovative Therapies, Inc.
OVIT
OncoVista Innovative Therapies, Inc.
2
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · GBIM peer comparison

About GBIM employees

GBIM Employees · Headcount

GlobeImmune, Inc. (GBIM) employee data is sourced from the annual SEC 10-K filing. As of 2015, GlobeImmune, Inc. had 2 full-time employees globally. Full-time employees only. Global consolidated headcount.

GlobeImmune, Inc. employs 2 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $3.23M, reflecting the company's operational efficiency.

GlobeImmune, Inc.'s workforce decreased by 20 (90.91%) in 2015 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

GlobeImmune, Inc.'s revenue per employee of $3.23M positions it among the notable performers in the Biotechnology sector for operational efficiency.

Frequently Asked Questions

GBIM Employees · 5 questions

As of the latest SEC 10-K filing (2015), GlobeImmune, Inc. had 2 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

GlobeImmune, Inc. employee counthow many employees does GlobeImmune, Inc. haveGBIM total employees 2015

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2016-03-16